Synergistic antiproliferative effects of methotrexate-loaded smart silica nanocomposites in MDA-MB-231 breast cancer cells

References

• Ahamed M. 2013. Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells. Hum Exp Toxicol. 32:186.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Ahmad M, Akhtar MJ, Alrokayan SA, Siddiqui MA, Musarrat J, Al-Khedhairy AA. 2012. Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. Toxicol Appl Pharmacol. 259:160–168
   PubMed Web of Science ®Google Scholar
• Ahmad M, Akhtar MJ, Siddiqui MA, Ahmad J, Musarrat J, Al-Khedhairy AA, et al. 2011. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology. 283:101–108.
   PubMed Web of Science ®Google Scholar
• Akhtar MJ, Ahamed M, Kumar S, Siddiqui H, Patil G, Ashquin M, Ahmad I. 2010. Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology. 276:95–102.
   PubMed Web of Science ®Google Scholar
• Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. 2005. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 353:1784.
   PubMed Web of Science ®Google Scholar
• Chidambaram M, Manavalan R, Kathiresan K. 2011. Nanotherapeutics to overcome conventional cancer chemotherapy limitations J Pharm Pharm Sci. 14:67.
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, Chen ZG, Shin DM. 2008. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 14:1310.
   PubMed Web of Science ®Google Scholar
• Dong L, WangWang F, Stoner M, Reed JC, Harigai M, Samudio I, et al. 1999. 26 Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem. 274:32099.
   PubMed Web of Science ®Google Scholar
• Ferrari M. 2005. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 5:161–171.
   PubMed Web of Science ®Google Scholar
• Gaies E, Jebabli N, Trabelsi S, Salouage I, Charfi R, Lakhal M, Klouz A. 2012. Methotrexate side effects: review article. Drug Metab Toxicol. 3:1000125.
   Google Scholar
• Ghanbari P, Mohseni M, Tabasinezhad M, Yousefi B, Saei AA, Sharifi S, et al. 2014. Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine. Appl Biochem Biotechnol. 6:1125.
   Google Scholar
• Gottesman MM. 2002. Mechanisms of cancer drug resistance. Annu Rev Med. 53:615.
   PubMed Web of Science ®Google Scholar
• Hassan MS, Ansari J, Spooner D, Hussain SA. 2010. Chemotherapy for breast cancer (Review). Oncol Rep. 24:1121.
   PubMed Web of Science ®Google Scholar
• Huang DM, Hung Y, Ko BS, Hsu SC, Chen WH, Chien CL, et al. 2005. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J. 19:2014
   PubMed Web of Science ®Google Scholar
• Krajewski S, Krajewska M, Turner BC, Pratt C, Howard B, Zapata JM, et al. 1999. Prognostic significance of apoptosis regulators in breast cancer. Relat Endocr Cancer. 6:29.
   PubMed Web of Science ®Google Scholar
• Lin YS, Tsai CP, Huang HY, Kuo CT, Hung Y, Huang DM, et al. 2005. Effect of the chemical composition on the work function of gold substrates modified by binary self-assembled monolayers. Chem Mater. 17:4570.
   Web of Science ®Google Scholar
• Montalti M, Prodi L, Rampazzo E, Zaccheroni N. 2014. Dye-doped silica nanoparticles as luminescent organized systems for nanomedicine. Chem Soc Rev. 43:4243–4268.
   PubMed Web of Science ®Google Scholar
• Mukerjee A, Ranjan AP, Vishwanatha JK. 2012. Combinatorial nanoparticles for cancer diagnosis and therapy. Curr Med Chem. 19:3714.
   PubMed Web of Science ®Google Scholar
• Napierska D, Rabolli V, Thomassen LC, Dinsdale D, Princen C, Gonzalez L, et al. 2012.Oxidative stress induced by pure and iron-doped amorphous silica nanoparticles in subtoxicconditions. Chem Res Toxicol. 25:828.
   Google Scholar
• Patr AK, Kukowska-Latallo JF, Baker JR. 2005. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev. 57:2203.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. 2002. Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res. 30:e36.
   PubMed Web of Science ®Google Scholar
• Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY. 2004. A polyamidoaminedendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. Chem Soc.126:13216.
   PubMed Web of Science ®Google Scholar
• Rani D, Somasundaram VH, Nair S, Koyakutty M. 2012. Advances in cancer nanomedicine. J Indian Inst Sci. 99:188–218.
   Google Scholar
• Rasouli S, Davaran S, Rasouli F, Mahkam M, Salehi R. 2014a. Positively charged functionalized silica nanoparticles as nontoxic carriers for triggered anticancer drug release. Des Monomers Polym.17:227.
   Web of Science ®Google Scholar
• Rasouli S, Davaran S, Rasouli F, Mahkam M, Salehi R. 2014b. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. Drug Deliv. 21:155.
   PubMed Web of Science ®Google Scholar
• Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL. 2002. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene. 21:7611.
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson JE, Sahlgren C, Lindén M. 2010. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small. 6:1234.
   PubMed Web of Science ®Google Scholar
• Salehi R, Hamishehkar H, Eskandani M, Mahkam M, Davaran S. 2014a. Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs. J Drug Target. 22:327.
   PubMed Web of Science ®Google Scholar
• Salehi R, Irani M, Eskandani M, Nowruzi K, Davaran S, Haririan I. 2014b. Controlled release, and antitumor activity of doxorubicin hydrochloride from pH-sensitive P(NIPAAm-MAA-VP) nanofibrous scaffolds prepared by green electrospinning. Int J Polym Mater Polym BioMater. 63:609–619.
   Web of Science ®Google Scholar
• Salehi R, Irani M, Rashidi MR, Aroujalian A, Raisi A, Eskandani M, et al. 2013. Stimuli-responsive nanofibers prepared from poly(N-isopropylacrylamide-acrylamidevinylpyrrolidone) by electrospinning as an anticancer drug delivery. Des Monomers Polym. 16:515.
   Web of Science ®Google Scholar
• Samadi N, Bekele R, Capatos D, Venkatraman G, Sariahmetoglu M, Brindley DN. 2011. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochemie. 93:61.
   PubMed Web of Science ®Google Scholar
• Sun L, Li Y, Liu X, Jin M, Zhang L, Du Z, et al. 2011. Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol In Vitro 25:1619.
   PubMed Web of Science ®Google Scholar
• Wani A, Muthuswamy E, Savithra GH, Mao G, Brock S, Oupický D. 2012. Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone. Pharm Res. 29:2407.
   PubMed Web of Science ®Google Scholar
• Worm J, Kirkin AF, Dzhandzhugazyan KN, Guldberg P. 2001. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells. J Cells Biol Chem. 276:39990.
   PubMed Web of Science ®Google Scholar
• Wu Z, Shah A, Patel N, Yuan X. 2010. Development of methotrexate prolineprodrug to overcome resistance by MDA-MB-231. Bioorg Med Chem Lett. 20:5108.
   PubMed Web of Science ®Google Scholar